CasLoc logo
All Cases PTAB Litigations UPC Oppositions

GENENTECH, INC. v. CELLTRION, INC.

1:18-cv-11553

Overview

Case Number 1:18-cv-11553
Filing Date 2018-07-11
Status Terminated
Termination Date 2018-09-07
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:1338 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

TEVA PHARMACEUTICALS INTERNATIONAL GmbH Operating Company

Represented By

0 Attorneys Listed
No attorneys available

TEVA PHARMACEUTICALS USA, INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

CELLTRION HEALTHCARE CO., LTD. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

CELLTRION, INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

CITY OF HOPE NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

KEITH J. MILLER

ROBINSON MILLER LLC

Tel: +1 (973) 690-5400
Fax: +1 (973) 466-2760

ROBINSON MILLER LLC, IRONSIDE NEWARK

HOFFMAN-LA ROCHE INC. Operating Company

Represented By

1 Attorneys Listed

KEITH J. MILLER

ROBINSON MILLER LLC

Tel: +1 (973) 690-5400
Fax: +1 (973) 466-2760

ROBINSON MILLER LLC, IRONSIDE NEWARK

BIOGEN, INC. Operating Company

Represented By

1 Attorneys Listed

KEITH J. MILLER

ROBINSON MILLER LLC

Tel: +1 (973) 690-5400
Fax: +1 (973) 466-2760

ROBINSON MILLER LLC, IRONSIDE NEWARK

GENENTECH, INC. Operating Company

Represented By

1 Attorneys Listed

KEITH J. MILLER

ROBINSON MILLER LLC

Tel: +1 (973) 690-5400
Fax: +1 (973) 466-2760

ROBINSON MILLER LLC, IRONSIDE NEWARK

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 8 proceedings
πŸ›οΈ
USPTO PTAB Trials 6 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (14 found):
PTAB: 6 U.S. Courts: 8
USPTO PTAB Trial 2016-10-11
IPR2017-00047

Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-07-07
IPR2016-01373

Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2016-03-03
IPR2016-00710

Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-01-15
IPR2016-00460

Genzyme Corporation et al. v. GENENTECH, INC. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2015-12-30
IPR2016-00383

GENZYME CORPORATION et al. v. Genentech Inc. et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2015-07-27
IPR2015-01624

Sanofi-Aventis U.S. LLC et al. v. Genentech, Inc. et al.

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2019-04-05
1:19-cv-00638

Genentech, Inc. v. Pfizer Inc.

Asserted Patent
Status: DED
U.S. District Court 2019-03-29
1:19-cv-00602

Genentech, Inc. v. Immunex Rhode Island Corp.

Asserted Patent
Status: DED
U.S. District Court 2018-09-04
1:18-cv-01363

Genentech, Inc. v. Samsung Bioepis Co., Ltd.

Asserted Patent
Status: DED
U.S. District Court 2018-01-12
1:18-cv-00095

Genentech, Inc. v. Celltrion, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-10-18
1:17-cv-01471

Genentech, Inc. v. Amgen, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-10-06
1:17-cv-01407

Genentech, Inc. v. Amgen Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-10-01
2:13-cv-07248

Eli Lilly and Company v. Genentech, Inc.

Asserted Patent
Status: CACD
U.S. District Court 2010-04-15
2:10-cv-02764

Glaxo Group Limited v. Genentech, Inc.

Asserted Patent
Status: CACD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6331415
Filed: β€”
Issued: β€”
Term Verification Pending
Expires: β€”

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Motion to Strike / Sanctions 1

Key Dispositive Motions & Rulings

Motion to Strike / Sanctions Pending / Under Review
COMPLAINT against All Defendants ( Filing and Admin fee $ 400 receipt number 0312-8876228) with JURY DEMAND, filed by GENENTECH, INC., CITY OF HOPE, HOFFMAN-LA ...
Entry #1 • 2018-07-11 Document →

Docket Entries

(7 total)
Motion to Strike / Sanctions Pending / Under Review

COMPLAINT against All Defendants ( Filing and Admin fee $ 400 receipt number 0312-8876228) with JURY DEMAND, filed by GENENTECH, INC., CITY OF HOPE, HOFFMAN-LA ROCHE INC., BIOGEN, INC.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Civil Cover Sheet, # 21 Certification Rule 11.2)(MILLER, KEITH) (Entered: 07/11/2018)

Entry #1 • 2018-07-11
1

Judge Renee Marie Bumb and Magistrate Judge Karen M. Williams added. (dd, )

Entry #2 • 2018-07-11
1
No Actions

SUMMONS ISSUED as to CELLTRION HEALTHCARE CO., LTD., CELLTRION, INC., TEVA PHARMACEUTICALS INTERNATIONAL GmbH, TEVA PHARMACEUTICALS USA, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *CHRISTOPHER YOOS* (cry, ) (Entered: 07/13/2018)

Entry #2 • 2018-07-13
1

Notice of Judicial Preferences. Click here for the Judge's Individual Procedure Requirements. (cry, )

Entry #4 • 2018-07-13
1
No Actions
Court Order

ORDER OF CONSOLIDATION FOR ALL PURPOSES. Signed by Judge Renee Marie Bumb on 9/6/2018. (rtm, ) (Entered: 09/07/2018)

Entry #3 • 2018-09-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc